TUMOUR LYSIS SYNDROME side effect
What is TUMOUR LYSIS SYNDROME ?Drugs associated with TUMOUR LYSIS SYNDROME
ALLOPURINOL ARRANON AVASTIN BRIPLATIN CAMPATH CARBOPLATIN CISPLATIN CYCLOPHOSPHAMIDE CYTARABINE DECADRON ERBITUX ERLOTINIB ETOPOSIDE GANCICLOVIR GEMCITABINE GEMTUZUMAB GLEEVEC INTERFERON IRINOTECAN MABTHERA METHOTREXATE REVLIMID RITUXAN RITUXIMAB SUTENT TAXOL VELCADETUMOUR LYSIS SYNDROME : Cisplatin Side Effects Report #5648260-3
Health Professional from KOREA, REPUBLIC OF reported CISPLATIN problem on Feb 28, 2008. Male patient, 38 years of age, was diagnosed with metastatic gastric cancer and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . CISPLATIN dosage: unknown. During the same period patient was treated with CAPECITABINE. Patient recovered.
TUMOUR LYSIS SYNDROME : Cisplatin Side Effects Report #5661349-8
CISPLATIN problem was reported by a Consumer or non-health professional from on Feb 28, 2008. Male patient was diagnosed with metastatic gastric cancer and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . CISPLATIN dosage: 60 MG/M2 ON DAY 1. During the same period patient was treated with CAPECITABINE. Patient recovered.
TUMOUR LYSIS SYNDROME : Erbitux Side Effects Report #5671054-X
Physician from UNITED STATES reported ERBITUX problem on Mar 17, 2008. Male patient, weighting 148.0 lb, was diagnosed with colon cancer metastatic and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . ERBITUX dosage: 400MG/M2 ONCE IV. Patient died on 01/28/2008.
TUMOUR LYSIS SYNDROME : Erlotinib Side Effects Report #5692110-6
ERLOTINIB problem was reported by a Physician from JAPAN on Feb 14, 2008. Female patient, 56 years of age, was diagnosed with lung neoplasm malignant and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . ERLOTINIB dosage: (150 MG,QD), ORAL. During the same period patient was treated with ALDACTONE, CYTOTEC, VOLTAREN, HOCHU, LASIX, MEXITIL, METHYCOBAL, NOVAMIN. Patient recovered.
TUMOUR LYSIS SYNDROME : Cisplatin Side Effects Report #5642581-6
Health Professional from KOREA, REPUBLIC OF reported CISPLATIN problem on Feb 25, 2008. Male patient, 38 years of age, was diagnosed with metastatic gastric cancer and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . CISPLATIN dosage: unknown. During the same period patient was treated with CAPECITABINE. Patient recovered.
TUMOUR LYSIS SYNDROME : Velcade Side Effects Report #5584698-0
VELCADE problem was reported by a Physician from JAPAN on Dec 20, 2007. Male patient, 47 years of age, weighting 127.9 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . VELCADE dosage: 1.70 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, BAKTAR, LANSOPRAZOLE, GASMOTIN, PLATELETS, RED BLOOD CELLS. Patient died on 08/14/2007.
TUMOUR LYSIS SYNDROME : Velcade Side Effects Report #5536812-0
Physician from JAPAN reported VELCADE problem on Nov 27, 2007. Male patient, 58 years of age, weighting 103.6 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . VELCADE dosage: 2.00 MG, INTRAVENOUS. Patient recovered.
TUMOUR LYSIS SYNDROME : Velcade Side Effects Report #5552416-8
VELCADE problem was reported by a Physician from JAPAN on Nov 29, 2007. Male patient, 58 years of age, weighting 103.6 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . VELCADE dosage: 2.00 MG, INTRAVENOUS. Patient recovered.
TUMOUR LYSIS SYNDROME : Velcade Side Effects Report #5569986-6
Physician from JAPAN reported VELCADE problem on Dec 07, 2007. Male patient, 58 years of age, weighting 103.6 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . VELCADE dosage: 2.00 MG, INTRAVENOUS. Patient recovered.
TUMOUR LYSIS SYNDROME : Revlimid Side Effects Report #5570547-3
REVLIMID problem was reported by a Health Professional from UNITED STATES on Dec 12, 2007. Female patient was diagnosed with chronic lymphocytic leukaemia and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . REVLIMID dosage: unknown. Patient recovered.
TUMOUR LYSIS SYNDROME : Revlimid Side Effects Report #5570574-6
Pharmacist from UNITED STATES reported REVLIMID problem on Dec 11, 2007. Female patient, 64 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . REVLIMID dosage: 25 MG, OD, ORAL. During the same period patient was treated with DEXAMETHASONE, ATENOLOL, ALLOPURINOL, LEVOTHYROXINE, POTASSIUM, LASIX. Patient recovered.
TUMOUR LYSIS SYNDROME : Revlimid Side Effects Report #5581099-6
REVLIMID problem was reported by a Health Professional from UNITED STATES on Dec 26, 2007. Female patient was diagnosed with chronic lymphocytic leukaemia and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . REVLIMID dosage: unknown. Patient recovered.
TUMOUR LYSIS SYNDROME : Etoposide Side Effects Report #5521592-5
Health Professional from DENMARK reported ETOPOSIDE problem on Nov 05, 2007. Male patient, 23 years of age, was diagnosed with medulloblastoma and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . ETOPOSIDE dosage: 50 MG/M2 Q D X 5 D, Q 3 WEEKS. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.
TUMOUR LYSIS SYNDROME : Sutent Side Effects Report #5524210-5
SUTENT problem was reported by a Physician from UNITED STATES on Nov 09, 2007. Female patient, weighting 169.3 lb, was diagnosed with clear cell carcinoma of the kidney, nausea, insomnia, urinary tract infection, pain and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . SUTENT dosage: unknown. During the same period patient was treated with COMPAZINE, ATIVAN, AMBIEN, LEVAQUIN, MAGIC MOUTHWASH, VIVELLE, PROZAC, ALLEGRA. Patient died on 09/10/2007.
TUMOUR LYSIS SYNDROME : Cytarabine Side Effects Report #5532122-6
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on Nov 30, 2007. Male patient, weighting 249.1 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . CYTARABINE dosage: 484 MG. During the same period patient was treated with DAUNORUBICIN, ETOPOSIDE. Patient was hospitalized. Patient recovered.
TUMOUR LYSIS SYNDROME : Erbitux Side Effects Report #5475005-2
ERBITUX problem was reported by a Physician from GERMANY on Sept 24, 2007. Male patient, 53 years of age, was diagnosed with lip and/or oral cavity cancer and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . ERBITUX dosage: unknown. During the same period patient was treated with DICLOFENAC, NOVAMINSULFON, METOPROLOL, PANTOPRAZOLE, CANDESARTAN CILEXETIL. Patient was hospitalized. Patient died on 08/20/2007.
TUMOUR LYSIS SYNDROME : Ganciclovir Side Effects Report #5480475-X
Health Professional from UNITED STATES reported GANCICLOVIR problem on Sept 27, 2007. Female patient was treated with GANCICLOVIR. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . GANCICLOVIR dosage: unknown. During the same period patient was treated with ARGININE BUTYRATE. Patient died.
TUMOUR LYSIS SYNDROME : Ganciclovir Side Effects Report #5480479-7
GANCICLOVIR problem was reported by a Health Professional from UNITED STATES on Sept 27, 2007. Female patient was diagnosed with t-cell lymphoma and was treated with GANCICLOVIR. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . GANCICLOVIR dosage: unknown. During the same period patient was treated with ARGININE BUTYRATE. Patient died.
TUMOUR LYSIS SYNDROME : Ganciclovir Side Effects Report #5480484-0
Physician from UNITED STATES reported GANCICLOVIR problem on Sept 27, 2007. Female patient was diagnosed with t-cell lymphoma and was treated with GANCICLOVIR. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . GANCICLOVIR dosage: unknown. During the same period patient was treated with ARGININE BUTYRATE. Patient died.
TUMOUR LYSIS SYNDROME : Ganciclovir Side Effects Report #5480536-5
GANCICLOVIR problem was reported by a Health Professional from UNITED STATES on Sept 27, 2007. Female patient was treated with GANCICLOVIR. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . GANCICLOVIR dosage: unknown. During the same period patient was treated with ARGININE BUTYRATE. Patient died.
TUMOUR LYSIS SYNDROME : Ganciclovir Side Effects Report #5480591-2
Health Professional from UNITED STATES reported GANCICLOVIR problem on Sept 27, 2007. Female patient was diagnosed with t-cell lymphoma and was treated with GANCICLOVIR. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . GANCICLOVIR dosage: unknown. During the same period patient was treated with ARGININE BUTYRATE. Patient died.
TUMOUR LYSIS SYNDROME : Ganciclovir Side Effects Report #5480611-5
GANCICLOVIR problem was reported by a Physician from UNITED STATES on Sept 27, 2007. Female patient was diagnosed with t-cell lymphoma and was treated with GANCICLOVIR. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . GANCICLOVIR dosage: unknown. During the same period patient was treated with ARGININE BUTYRATE. Patient died.
TUMOUR LYSIS SYNDROME : Erbitux Side Effects Report #5481382-9
Physician from GERMANY reported ERBITUX problem on Oct 02, 2007. Male patient, 52 years of age, was diagnosed with lip and/or oral cavity cancer and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . ERBITUX dosage: unknown. During the same period patient was treated with VOLTAREN, NOVAMINSULFON, METOPROLOL TARTRATE, PANTOPRAZOLE, ATACAND HCT, BISACODYL. Patient was hospitalized. Patient died on 08/21/2007.
TUMOUR LYSIS SYNDROME : Avastin Side Effects Report #5492644-3
AVASTIN problem was reported by a Physician from UNITED STATES on Oct 10, 2007. Female patient was diagnosed with non-small cell lung cancer and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . AVASTIN dosage: unknown. During the same period patient was treated with CARBOPLATIN, TAXOL. Patient recovered.
TUMOUR LYSIS SYNDROME : Gemcitabine Side Effects Report #5503144-6
Physician from TAIWAN, PROVINCE OF CHINA reported GEMCITABINE problem on Oct 17, 2007. Female patient, 75 years of age, was diagnosed with transitional cell carcinoma and was treated with GEMCITABINE. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . GEMCITABINE dosage: 1200 MG/M2, AS A 30 MINUTES INFUSION. Patient was hospitalized. Patient died.
TUMOUR LYSIS SYNDROME : Sutent Side Effects Report #5457840-X
SUTENT problem was reported by a Health Professional from UNITED STATES on Sept 10, 2007. Female patient was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . SUTENT dosage: unknown. Patient died.
TUMOUR LYSIS SYNDROME : Sutent Side Effects Report #5429887-0
Consumer or non-health professional from UNITED STATES reported SUTENT problem on Aug 15, 2007. Male patient, 56 years of age, was diagnosed with gastrointestinal stromal tumour and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: tumour lysis syndrome, . SUTENT dosage: unknown. Patient died.
TUMOUR LYSIS SYNDROME : Velcade Side Effects Report #5615692-9
VELCADE problem was reported by a Physician from JAPAN on Jan 23, 2008. Female patient, 73 years of age, weighting 134.5 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: capillary leak syndrome, tumour lysis syndrome, . VELCADE dosage: unknown. Patient was hospitalized. Patient recovered.
TUMOUR LYSIS SYNDROME : Revlimid Side Effects Report #5583865-X
Health Professional from UNITED STATES reported REVLIMID problem on Dec 21, 2007. Male patient, 79 years of age, weighting 166.9 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: blood creatine increased, tumour lysis syndrome, . REVLIMID dosage: 2.5 MG, DAILY, ORAL. During the same period patient was treated with ALLOPURINOL, ANTIBIOTIC. Patient was hospitalized. Patient recovered.
TUMOUR LYSIS SYNDROME : Velcade Side Effects Report #5584689-X
VELCADE problem was reported by a Physician from JAPAN on Dec 19, 2007. Male patient, 58 years of age, weighting 103.6 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: dialysis, tumour lysis syndrome, . VELCADE dosage: 2.00 MG, INTRAVENOUS. Patient died on 12/12/2007.
TUMOUR LYSIS SYNDROME : Irinotecan Side Effects Report #5584703-1
Consumer or non-health professional from GERMANY reported IRINOTECAN problem on Jan 02, 2008. Male patient, 62 years of age, was treated with IRINOTECAN. After drug was administered, patient experienced the following problems/side effects: diarrhoea, tumour lysis syndrome, . IRINOTECAN dosage: unknown. During the same period patient was treated with FLUOROURACIL, FOLINIC ACID, FOLINIC ACID, BEVACIZUMAB. Patient died.
TUMOUR LYSIS SYNDROME : Avastin Side Effects Report #5592391-3
AVASTIN problem was reported by a Physician from GERMANY on Jan 07, 2008. Male patient, 62 years of age, was diagnosed with colorectal cancer metastatic, colon cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: renal failure acute, tumour lysis syndrome, . AVASTIN dosage: 5 MG/KG, UNK. During the same period patient was treated with IRINOTECAN, FOLINIC ACID, FLUOROURACIL. Patient died.
TUMOUR LYSIS SYNDROME : Campath Side Effects Report #5603709-7
Physician from UNITED STATES reported CAMPATH problem on Jan 15, 2008. Male patient, 20 years of age, weighting 233.7 lb, was diagnosed with acute lymphocytic leukaemia and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, tumour lysis syndrome, white blood cell count decreased, . CAMPATH dosage: unknown. During the same period patient was treated with METHOTREXATE, VINCRISTINE, ELSPAR, DEXAMETHASONE. Patient was hospitalized. Patient recovered.
TUMOUR LYSIS SYNDROME : Campath Side Effects Report #5607656-6
CAMPATH problem was reported by a Physician from UNITED STATES on Jan 18, 2008. Male patient, 20 years of age, weighting 233.7 lb, was diagnosed with acute lymphocytic leukaemia and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, tumour lysis syndrome, white blood cell count decreased, . CAMPATH dosage: unknown. During the same period patient was treated with METHOTREXATE, VINCRISTINE, ELSPAR, DEXAMETHASONE. Patient was hospitalized. Patient recovered.
TUMOUR LYSIS SYNDROME : Taxol Side Effects Report #5564374-0
Health Professional from JAPAN reported TAXOL problem on Dec 12, 2007. Female patient, 60 years of age, was diagnosed with breast cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: disseminated intravascular coagulation, tumour lysis syndrome, . TAXOL dosage: unknown. Patient died.
TUMOUR LYSIS SYNDROME : Rituximab Side Effects Report #5509091-8
RITUXIMAB problem was reported by a Consumer or non-health professional from FRANCE on Oct 29, 2007. Male patient, weighting 160.9 lb, was diagnosed with b-cell lymphoma and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, tumour lysis syndrome, . RITUXIMAB dosage: 690 MG, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient recovered.
TUMOUR LYSIS SYNDROME : Decadron Side Effects Report #5512950-3
Physician from JAPAN reported DECADRON problem on Nov 05, 2007. Male patient, 71 years of age, was diagnosed with multiple myeloma and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: bone marrow failure, tumour lysis syndrome, . DECADRON dosage: unknown. During the same period patient was treated with VELCADE. Patient recovered.
TUMOUR LYSIS SYNDROME : Decadron Side Effects Report #5521014-4
DECADRON problem was reported by a Physician from JAPAN on Nov 07, 2007. Male patient, 71 years of age, was diagnosed with multiple myeloma and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: bone marrow failure, tumour lysis syndrome, . DECADRON dosage: unknown. During the same period patient was treated with VELCADE. Patient recovered.
TUMOUR LYSIS SYNDROME : Allopurinol Side Effects Report #5528378-6
Health Professional from UNITED KINGDOM reported ALLOPURINOL problem on Nov 07, 2007. Female patient, 47 years of age, was diagnosed with chronic myeloid leukaemia and was treated with ALLOPURINOL. After drug was administered, patient experienced the following problems/side effects: renal failure, tumour lysis syndrome, . ALLOPURINOL dosage: unknown. During the same period patient was treated with CYTARABINE, FLUDARABINE PHOSPHATE, IDARUBICIN, RASBURICASE. Patient was hospitalized. Patient recovered.
TUMOUR LYSIS SYNDROME : Allopurinol Side Effects Report #5530259-9
ALLOPURINOL problem was reported by a Health Professional from UNITED KINGDOM on Nov 12, 2007. Male patient, 43 years of age, was treated with ALLOPURINOL. After drug was administered, patient experienced the following problems/side effects: renal failure acute, tumour lysis syndrome, . ALLOPURINOL dosage: unknown. Patient was hospitalized. Patient recovered.
TUMOUR LYSIS SYNDROME : Decadron Side Effects Report #5500024-7
Physician from JAPAN reported DECADRON problem on Oct 17, 2007. Male patient, 71 years of age, was diagnosed with multiple myeloma and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: bone marrow failure, tumour lysis syndrome, . DECADRON dosage: unknown. During the same period patient was treated with VELCADE. Patient recovered.
TUMOUR LYSIS SYNDROME : Briplatin Side Effects Report #5448580-1
BRIPLATIN problem was reported by a Health Professional from JAPAN on Sept 10, 2007. Male patient, 23 years of age, was diagnosed with medulloblastoma and was treated with BRIPLATIN. After drug was administered, patient experienced the following problems/side effects: renal failure acute, tumour lysis syndrome, . BRIPLATIN dosage: unknown. During the same period patient was treated with ETOPOSIDE. Patient recovered.
TUMOUR LYSIS SYNDROME : Rituxan Side Effects Report #5445170-1
Physician from UNITED STATES reported RITUXAN problem on May 29, 2007. Male patient, 62 years of age, was diagnosed with b-cell lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: renal failure, tumour lysis syndrome, . RITUXAN dosage: unknown. Patient died.
TUMOUR LYSIS SYNDROME : Rituxan Side Effects Report #5445170-1
RITUXAN problem was reported by a Physician from UNITED STATES on May 29, 2007. Male patient, 62 years of age, was diagnosed with b-cell lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: renal failure, tumour lysis syndrome, . RITUXAN dosage: unknown. Patient died.
TUMOUR LYSIS SYNDROME : Arranon Side Effects Report #5672921-3
Consumer or non-health professional from UNITED STATES reported ARRANON problem on Mar 13, 2008. Male patient, 30 years of age, was treated with ARRANON. After drug was administered, patient experienced the following problems/side effects: peripheral sensory neuropathy, renal failure acute, tumour lysis syndrome, . ARRANON dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.
TUMOUR LYSIS SYNDROME : Gemtuzumab Side Effects Report #5611055-0
GEMTUZUMAB OZOGAMICIN problem was reported by a Physician from CANADA on Jan 30, 2008. Female patient, 58 years of age, weighting 198.4 lb, was diagnosed with acute myeloid leukaemia and was treated with GEMTUZUMAB OZOGAMICIN. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, septic shock, tumour lysis syndrome, . GEMTUZUMAB OZOGAMICIN dosage: 12 MG. During the same period patient was treated with CYTARABINE, DAUNORUBICIN. Patient was hospitalized. Patient died on 01/19/2008.
TUMOUR LYSIS SYNDROME : Mabthera Side Effects Report #5616057-6
Consumer or non-health professional from UNITED KINGDOM reported MABTHERA problem on Jan 24, 2008. Male patient was diagnosed with b-cell lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: mycosis fungoides, t-cell lymphoma, tumour lysis syndrome, . MABTHERA dosage: unknown. Patient died.
TUMOUR LYSIS SYNDROME : Taxol Side Effects Report #5630385-X
TAXOL problem was reported by a Health Professional from JAPAN on Feb 13, 2008. Female patient, 60 years of age, was diagnosed with breast cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: disseminated intravascular coagulation, respiratory arrest, tumour lysis syndrome, . TAXOL dosage: unknown. Patient died on 07/02/2007.
TUMOUR LYSIS SYNDROME : Taxol Side Effects Report #5638952-4
Health Professional from JAPAN reported TAXOL problem on Feb 25, 2008. Female patient, 60 years of age, was diagnosed with breast cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: disseminated intravascular coagulation, respiratory arrest, tumour lysis syndrome, . TAXOL dosage: unknown. Patient died on 07/02/2007.
TUMOUR LYSIS SYNDROME : Taxol Side Effects Report #5644361-4
TAXOL problem was reported by a Health Professional from JAPAN on Feb 25, 2008. Female patient, 60 years of age, was diagnosed with breast cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: disseminated intravascular coagulation, respiratory arrest, tumour lysis syndrome, . TAXOL dosage: unknown. Patient died on 07/02/2007.
TUMOUR LYSIS SYNDROME : Decadron Side Effects Report #5592560-2
Physician from JAPAN reported DECADRON problem on Dec 12, 2007. Female patient was diagnosed with acute lymphocytic leukaemia and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: haemorrhage intracranial, renal failure, tumour lysis syndrome, . DECADRON dosage: unknown. During the same period patient was treated with CYCLOCIDE N, LEUNASE, CYCLOPHOSPHAMIDE, PIRARUBICIN, FILDESIN. Patient died.